TSX:CURAPharmaceuticals
Will Curaleaf’s (TSX:CURA) 2025 Revenue Drop and Wider Losses Shift Its Profitability Narrative?
Curaleaf Holdings, Inc. has released its fourth-quarter and full-year 2025 results, reporting Q4 revenue of US$333.07 million and a net loss of US$59.82 million, while full-year revenue reached US$1.27 billion with a net loss of US$231.07 million.
The contrast between quarterly revenue growth and a smaller Q4 loss versus a full-year revenue decline and higher annual net loss highlights ongoing pressure on the company’s path toward profitability.
We’ll now examine how the full-year revenue...